文献速递头痛与眩晕

特发性颅内高压女性的头痛、阿片类药物使用及处方趋势:一项基于人群的匹配队列研究

Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study.
PubMed 文献 · Neurology · 2022-10-31

本研究基于英国IQVIA医学研究数据(1995年1月1日至2019年9月25日),纳入3411例特发性颅内高压(IIH)女性、13966例偏头痛对照和33495例人群对照,匹配年龄和体重指数。IIH女性新发头痛的调整风险比为3.09(95%CI 2.78-3.43)。诊断后第一年,58%的IIH女性被处方乙酰唑胺,20%被处方托吡酯;20%的IIH女性在诊断后第一年内被处方阿片类药物,6年后降至17%,而偏头痛对照分别为8%和11%。IIH女性阿片类药物处方量是偏头痛对照的2倍,是人群对照的3倍,且头痛预防药物处方更多。

要点

  • IIH女性新发头痛风险显著高于人群对照,调整风险比为3.09(95%CI 2.78-3.43)。
  • 诊断后第一年,58%的IIH女性被处方乙酰唑胺,20%被处方托吡酯。
  • IIH女性阿片类药物处方量是偏头痛对照的2倍,是人群对照的3倍。

核心结论

  • IIH女性相比偏头痛对照和人群对照更可能被处方阿片类药物和简单镇痛药。
  • IIH女性病程中尝试更多预防性药物,提示IIH头痛可能更难治。

研究设计与样本

  • 基于人群的匹配回顾性队列研究,使用英国IQVIA医学研究数据(1995年1月1日至2019年9月25日)。
  • 纳入16岁及以上女性,IIH组按年龄和体重指数与偏头痛对照(无IIH但有偏头痛)及人群对照(无IIH无偏头痛)匹配,最多1:10匹配。
  • 共纳入3411例IIH女性、13966例偏头痛对照和33495例人群对照。
  • 采用横断面分析描述药物处方模式。

主要发现

  • IIH女性新发头痛的调整风险比为3.09(95%CI 2.78-3.43),对照为人群对照。
  • 诊断后第一年,58%的IIH女性被处方乙酰唑胺,20%被处方托吡酯。
  • 诊断后第一年内,20%的IIH女性被处方阿片类药物,6年后降至17%;偏头痛对照分别为8%和11%。
  • IIH女性阿片类药物处方量是偏头痛对照的2倍,是人群对照的3倍。
  • IIH女性比偏头痛对照被处方更多头痛预防药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Physician prescribing habits for opiates and headache therapies have not been previously evaluated in a large, matched cohort study in idiopathic intracranial hypertension (IIH). Our objective was to evaluate opiate and headache medication prescribing habits in women with IIH compared with matched women with migraine and population controls. We also investigated the occurrence of new onset headache in IIH compared with population controls. METHODS: We performed a population-based matched, retrospective cohort study to explore headache outcomes. Cross-sectional analyses were used to describe medication prescribing patterns. We used data from IQVIA Medical Research Data, an anonymized, nationally representative primary care electronic medical record database in the United Kingdom, from January 1, 1995, to September 25, 2019. Women aged 16 years and older were eligible for inclusion. Women with IIH (exposure) were matched by age and body mass index with up to 10 control women without IIH but with migraine (migraine controls), and without IIH or migraine (population controls). RESULTS: A total of 3,411 women with IIH, 13,966 migraine controls, and 33,495 population controls were included. The adjusted hazard ratio for new onset headache in IIH compared with population controls was 3.09 (95% CI 2.78-3.43). In the first year after diagnosis, 58% of women with IIH were prescribed acetazolamide and 20% topiramate. In total, 20% of women with IIH were prescribed opiates within the first year of their diagnosis, reducing to 17% after 6 years, compared with 8% and 11% among those with migraine, respectively. Twice as many women with IIH were prescribed opiates compared with migraine controls, and 3 times as many women with IIH were prescribed opiates compared with population controls. Women with IIH were also prescribed more headache preventative medications compared with migraine controls. DISCUSSION: Women with IIH were more likely to be prescribed opiate and simple analgesics compared with both migraine and population controls. Women with IIH trialed more preventative medications over their disease course suggesting that headaches in IIH may be more refractory to treatment.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Adderley NJ, Subramanian A, Perrins M, et al. Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study. Neurology. 2022. PMID: 35985824. doi:10.1212/WNL.0000000000201064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。